Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement

In order to improve the aqueous solubility and dissolution of Tacrolimus (TAC), amorphous solid dispersions of TAC were prepared by hot melt extrusion with three hydrophilic polymers, Polyvinylpyrrolidone vinyl acetate (PVP VA64), Soluplus® and Hydroxypropyl Cellulose (HPC), at a drug loading of 10%...

Full description

Bibliographic Details
Main Authors: Poovizhi Ponnammal, Parijat Kanaujia, Yin Yani, Wai Kiong Ng, Reginald B. H. Tan
Format: Article
Language:English
Published: MDPI AG 2018-03-01
Series:Pharmaceutics
Subjects:
Online Access:http://www.mdpi.com/1999-4923/10/1/35
_version_ 1818002006840705024
author Poovizhi Ponnammal
Parijat Kanaujia
Yin Yani
Wai Kiong Ng
Reginald B. H. Tan
author_facet Poovizhi Ponnammal
Parijat Kanaujia
Yin Yani
Wai Kiong Ng
Reginald B. H. Tan
author_sort Poovizhi Ponnammal
collection DOAJ
description In order to improve the aqueous solubility and dissolution of Tacrolimus (TAC), amorphous solid dispersions of TAC were prepared by hot melt extrusion with three hydrophilic polymers, Polyvinylpyrrolidone vinyl acetate (PVP VA64), Soluplus® and Hydroxypropyl Cellulose (HPC), at a drug loading of 10% w/w. Molecular modeling was used to determine the miscibility of the drug with the carrier polymers by calculating the Hansen Solubility Parameters. Powder X-ray diffraction and differential scanning calorimetry (DSC) studies of powdered solid dispersions revealed the conversion of crystalline TAC to amorphous form. Fourier transform Infrared (FTIR) spectroscopy results indicated formation of hydrogen bond between TAC and polymers leading to stabilization of TAC in amorphous form. The extrudates were found to be stable under accelerated storage conditions for 3 months with no re-crystallization, indicating that hot melt extrusion is suitable for producing stable amorphous solid dispersions of TAC in PVP VA64, Soluplus® and HPC. Stable solid dispersions of amorphous TAC exhibited higher dissolution rate, with the solid dispersions releasing more than 80% drug in 15 min compared to the crystalline drug giving 5% drug release in two hours. These stable solid dispersions were incorporated into orally-disintegrating tablets in which the solid dispersion retained its solubility, dissolution and stability advantage.
first_indexed 2024-04-14T03:40:26Z
format Article
id doaj.art-4e4b95ba75e04134bc97162979b87731
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-04-14T03:40:26Z
publishDate 2018-03-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-4e4b95ba75e04134bc97162979b877312022-12-22T02:14:32ZengMDPI AGPharmaceutics1999-49232018-03-011013510.3390/pharmaceutics10010035pharmaceutics10010035Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution EnhancementPoovizhi Ponnammal0Parijat Kanaujia1Yin Yani2Wai Kiong Ng3Reginald B. H. Tan4Institute of Chemical and Engineering Sciences, 1, Pesek Road Jurong Island, Singapore 627833, SingaporeInstitute of Chemical and Engineering Sciences, 1, Pesek Road Jurong Island, Singapore 627833, SingaporeInstitute of Chemical and Engineering Sciences, 1, Pesek Road Jurong Island, Singapore 627833, SingaporeInstitute of Chemical and Engineering Sciences, 1, Pesek Road Jurong Island, Singapore 627833, SingaporeInstitute of Chemical and Engineering Sciences, 1, Pesek Road Jurong Island, Singapore 627833, SingaporeIn order to improve the aqueous solubility and dissolution of Tacrolimus (TAC), amorphous solid dispersions of TAC were prepared by hot melt extrusion with three hydrophilic polymers, Polyvinylpyrrolidone vinyl acetate (PVP VA64), Soluplus® and Hydroxypropyl Cellulose (HPC), at a drug loading of 10% w/w. Molecular modeling was used to determine the miscibility of the drug with the carrier polymers by calculating the Hansen Solubility Parameters. Powder X-ray diffraction and differential scanning calorimetry (DSC) studies of powdered solid dispersions revealed the conversion of crystalline TAC to amorphous form. Fourier transform Infrared (FTIR) spectroscopy results indicated formation of hydrogen bond between TAC and polymers leading to stabilization of TAC in amorphous form. The extrudates were found to be stable under accelerated storage conditions for 3 months with no re-crystallization, indicating that hot melt extrusion is suitable for producing stable amorphous solid dispersions of TAC in PVP VA64, Soluplus® and HPC. Stable solid dispersions of amorphous TAC exhibited higher dissolution rate, with the solid dispersions releasing more than 80% drug in 15 min compared to the crystalline drug giving 5% drug release in two hours. These stable solid dispersions were incorporated into orally-disintegrating tablets in which the solid dispersion retained its solubility, dissolution and stability advantage.http://www.mdpi.com/1999-4923/10/1/35melt extrusionamorphous solid dispersiondissolution enhancementtacrolimusorally-disintegrating tablets
spellingShingle Poovizhi Ponnammal
Parijat Kanaujia
Yin Yani
Wai Kiong Ng
Reginald B. H. Tan
Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
Pharmaceutics
melt extrusion
amorphous solid dispersion
dissolution enhancement
tacrolimus
orally-disintegrating tablets
title Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
title_full Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
title_fullStr Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
title_full_unstemmed Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
title_short Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
title_sort orally disintegrating tablets containing melt extruded amorphous solid dispersion of tacrolimus for dissolution enhancement
topic melt extrusion
amorphous solid dispersion
dissolution enhancement
tacrolimus
orally-disintegrating tablets
url http://www.mdpi.com/1999-4923/10/1/35
work_keys_str_mv AT poovizhiponnammal orallydisintegratingtabletscontainingmeltextrudedamorphoussoliddispersionoftacrolimusfordissolutionenhancement
AT parijatkanaujia orallydisintegratingtabletscontainingmeltextrudedamorphoussoliddispersionoftacrolimusfordissolutionenhancement
AT yinyani orallydisintegratingtabletscontainingmeltextrudedamorphoussoliddispersionoftacrolimusfordissolutionenhancement
AT waikiongng orallydisintegratingtabletscontainingmeltextrudedamorphoussoliddispersionoftacrolimusfordissolutionenhancement
AT reginaldbhtan orallydisintegratingtabletscontainingmeltextrudedamorphoussoliddispersionoftacrolimusfordissolutionenhancement